ECI taps industry veteran Khalid Raja to drive strategic growth
Move comes amid rising regulatory pressures
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
Targets high-growth eye care expansion push
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Subscribe To Our Newsletter & Stay Updated